Savient Pharmaceuticals, Inc. (SVNT) Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
3/15/2010
More...
|
Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS)'s Mipomersen Phase 3 Study in HoFH Patients Featured in The Lancet
3/15/2010
More...
|
Novartis Corporation (NVS): NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance
3/15/2010
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer Vaccine
3/15/2010
More...
|
Initiation of Two Phase II Studies with Ipsen's Proprietary BIM 23A760 First-in-Class Chimeric Compound in the Treatment of Acromegaly and Carcinoid Syndrome Due to Neuroendocrine Tumors
3/15/2010
More...
|
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I - MRX-I Targets Multi-Drug Resistant Gram Positive Infections
3/15/2010
More...
|
FDA Allows IND for Bio-Path Holdings, Inc. (BPTH)'s Liposomal Grb-2
3/15/2010
More...
|
Alnylam Pharmaceuticals (ALNY) and Collaborators Present New Pre-Clinical Research on RNAi Therapeutics Targeting PCSK9
3/15/2010
More...
|
XOMA (US) LLC (XOMA) 052 Prevents Adverse Cardiac Remodeling in Animal Model of Heart Attack
3/15/2010
More...
|
Data Highlights Involvement of Immune System in Response to Provectus Pharmaceuticals Inc.'s PV-10 Therapy and Its Role in the Bystander Effect
3/15/2010
More...
|
Boehringer Ingelheim Corporation's Dabigatran Etexilate Shows Greater Reductions Than Warfarin in Stroke in Patients with Atrial Fibrillation across All Stroke Risk Groups
3/15/2010
More...
|
MDRNA, Inc. Demonstrates the Potential for Greater Efficacy in Cancer With an UsiRNA Combination Approach
3/15/2010
More...
|
Myriad Pharmaceuticals, Inc. Sets Date for Special Stockholder Meeting to Approve Merger with Javelin Pharmaceuticals (JAV)
3/15/2010
More...
|
Aceto Corporation Purchases Building: Future Location of Aceto's Global Headquarters
3/15/2010
More...
|
Nipro Corporation and Home Diagnostics, Inc. Announce Completion of Merger
3/15/2010
More...
|
Bio Base Europe: Flanders and the Netherlands Cooperate on Biofuels From Genetically Modified Poplars
3/15/2010
More...
|
Orexigen Therapeutics, Inc. (OREX) and Patheon (PTI.TO) Announce Exclusive Manufacturing Agreement for Contrave(R)
3/15/2010
More...
|
Sigma-Aldrich Corporation (SIAL) Reaches Agreement to Sell Pfizer Inc. (PFE)'s Bioactive Small Molecule Compounds
3/15/2010
More...
|
Enzo Biochem (ENZ)'s Clinical Lab Division Enters Exclusive Agreement with Novel Sequencing Provider MultiGEN Diagnostics
3/15/2010
More...
|
The Leukemia & Lymphoma Society And FORMA Therapeutics Enter a Drug Discovery Alliance to Discover and Develop Novel Therapies For Patients with Diffuse Large B Cell Lymphoma
3/15/2010
More...
|
Innate Immune, Inc. Enters into a License and Commercialization Agreement with Cephalon Australia Pty Ltd
3/15/2010
More...
|
Recordati S.p.A And Lee's Pharmaceutical Announce Partnership For Zanidip(R) In China
3/15/2010
More...
|
Dynavax Technologies Corporation (DVAX) and Merck & Co., Inc. (MRK) Agree on Final Reimbursements
3/15/2010
More...
|
Gamma Pharmaceuticals Announces Retention of Leading Investment Banking Boutique and National Law Firm to Advise on Financial and Strategic Alternatives
3/15/2010
More...
|
Perrigo Company (PRGO) Announces Launch of Generic Version of Zaditor(TM)
3/15/2010
More...
|
Neurologix, Inc. Receives Notice of Allowance for Epilepsy Therapeutic Approach
3/15/2010
More...
|
MorphoSys AG Granted Further Patent on its Core Antibody Technology in Japan
3/15/2010
More...
|
CTD Holdings, Inc. Formalizes International Sales of Trappsol(R) Cyclo(TM) for Treatment of Niemann-Pick Type C (NPC)
3/15/2010
More...
|
IMPAX Laboratories, Inc. (IPXL) Confirms Patent Challenge Relating to TRILIPIX(R) Delayed-Release Capsules, 135 mg and 45 mg
3/15/2010
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces $6.3 Million Financing
3/15/2010
More...
|
Otix Global, Inc. (OTIX) Extends Term of Loan and Security Agreement With Silicon Valley Bank
3/15/2010
More...
|
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustments to Convertible Notes
3/15/2010
More...
|
Cardium Therapeutics, Inc. (CXM) Announces Closing of $11.3 Million in Registered Direct Equity Offering
3/15/2010
More...
|
Orexo AB: Notice of Extraordinary General Meeting
3/15/2010
More...
|
CryoPort, Inc.'s Ticker Symbol to Revert Back to CYRX
3/15/2010
More...
|
Pharming Group (PHGUF.PK) to hold Extraordinary Shareholders' Meeting
3/15/2010
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Programme
3/15/2010
More...
|
Abbott Laboratories (ABT) Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use
3/15/2010
More...
|
Leatt Corporation Expands Sales Force and Effort
3/15/2010
More...
|
Vertellus Specialties Inc. Plans Significant Expansion of Vitride(R) Manufacturing Capacity
3/15/2010
More...
|
Caliper Life Sciences (CALP) Settles Outstanding Litigation with Shimadzu Corporation
3/15/2010
More...
|
Anti-Virus Machine Protects ‘High Rollers’ in $63 Billion Casino Market, Says Tri-Air Developments
3/15/2010
More...
|
CLC bio Expands Next Gen Sequencing Solutions With Ground-Breaking New Algorithm For Whole-Genome De Novo Assemblies
3/15/2010
More...
|
Seegene, Inc. Breaks Barriers of Conventional PCR and Real-Time PCR Techniques With Powerful New Platform for New Molecular Diagnostic Tests
3/15/2010
More...
|
Diagenode Introduces New Bioruptor Sonicator Models: Systems Optimized for High-Throughput and for Next Generation Sequencing Library Preparation
3/15/2010
More...
|
A.P. Pharma, Inc. (APPA) Announces Fourth Quarter and Year-End 2009 Financial Results
3/15/2010
More...
|
Antares Pharma, Inc. (ANTR) to Host Fourth Quarter and Full Year 2009 Earnings Call
3/15/2010
More...
|
CytRx Corporation (CYTR) Reports 2009 Fourth Quarter Financial Results
3/15/2010
More...
|
Enzo Biochem (ENZ) Reports Results for Second Fiscal Quarter
3/15/2010
More...
|
GTx, Inc. (GTXI) Provides Corporate Update and Reports 2009 Financial Results
3/15/2010
More...
|
Hemispherx Biopharma (HEB) Announces 2009 Financial Results
3/15/2010
More...
|
Insmed Incorporated (INSM) Announces Fourth Quarter and Full-Year 2009 Financial Results
3/15/2010
More...
|
Karolinska Development AB Announces Publication of Year End Report for 2009
3/15/2010
More...
|
MedQuist Reports Results for the Fourth Quarter and 2009
3/15/2010
More...
|
Progenics Pharmaceuticals, Inc. (PGNX) Announces Fourth Quarter and Year-End 2009 Financial Results
3/15/2010
More...
|
Omeros Corporation to Host Conference Call on Fourth Quarter and Full Year 2009 Results on March 31
3/15/2010
More...
|
Demand for PanGenex Corporation Products Continues at a Record Pace
3/15/2010
More...
|
Tekmira Pharmaceuticals Corporation Conference Call Advisory 2009 Audited Results and Corporate Update
3/15/2010
More...
|
Timothy Barabe Appointed Chief Financial Officer of Affymetrix (Santa Clara, California) (AFFX)
3/15/2010
More...
|
Crucell N.V. (CRXL)'s Supervisory Board Nominates Mr. W. Burns, Mr. J. Shannon And Mr. G. Siber As New Board Members
3/15/2010
More...
|
Urovalve's CEO Dr. Harvey Homan Appointed to National Institutes of Health (NIH)'s Center for Scientific Review (CSR)
3/15/2010
More...
|
OXiGENE (OXGN) Announces Change to Board of Directors
3/15/2010
More...
|
Shire Pharmaceuticals (SHPGY): New Board Director Appointed
3/15/2010
More...
|
Immunomedics, Inc. (IMMU) to Present at Barclays Capital 2010 Global Healthcare Conference
3/15/2010
More...
|
AMICAS, Inc. (AMCS) Announces Cardiology Clinical Reporting Milestone at American College of Cardiology
3/15/2010
More...
|
Siemens Highlights Its Commitment to Excellence in Cardiology at American College of Cardiology 2010
3/15/2010
More...
|
Regado Biosciences Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
3/15/2010
More...
|
Cypress Bioscience Inc. (CYPB) to Present at Roth 22nd Annual OC Growth Stock Conference
3/15/2010
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) to Present at the Barclays Capital Global Healthcare Conference
3/15/2010
More...
|
Genoptix, Inc. Announces Participation at the Barclays Capital 2010 Global Healthcare Conference
3/15/2010
More...
|